This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
| adjective | noun | frequency |
|---|---|---|
| - | cov | 6844 |
| respiratory | syndrome | 3183 |
| novel | coronavirus | 280 |
| human | coronavirus | 210 |
| human | transmission | 191 |
| infectious | diseases | 148 |
| - | coronavirus | 130 |
| respiratory | disease | 117 |
| infectious | virus | 112 |
| - | risk | 86 |
| human | infection | 84 |
| severe | disease | 81 |
| infectious | disease | 78 |
| human | cases | 74 |
| respiratory | infections | 71 |
| viral | infection | 58 |
| respiratory | viruses | 55 |
| - | patient | 55 |
| human | mers | 55 |
| respiratory | infection | 53 |
| - | cell | 52 |
| infected | camels | 51 |
| severe | mers | 51 |
| high | risk | 50 |
| specific | antibodies | 50 |
| other | countries | 48 |
| - | infection | 44 |
| human | infections | 44 |
| viral | infections | 44 |
| first | case | 37 |
| human | disease | 35 |
| other | viruses | 32 |
| severe | cases | 31 |
| severe | middle | 30 |
| new | coronavirus | 29 |
| potential | risk | 27 |
| respiratory | coronavirus | 27 |
| infected | patients | 26 |
| respiratory | diseases | 26 |
| new | virus | 24 |
| - | protein | 23 |
| other | studies | 23 |
| infected | animals | 22 |
| human | middle | 22 |
| - | animal | 21 |
| several | studies | 21 |
| different | countries | 20 |
| high | case | 20 |
| higher | risk | 20 |
| other | animals | 19 |
| infected | patient | 18 |
| viral | proteins | 18 |
| clinical | studies | 18 |
| human | antibodies | 18 |
| first | mers | 18 |
| large | outbreak | 17 |
| many | countries | 17 |
| other | mers | 17 |
| first | cases | 16 |
| large | outbreaks | 16 |
| novel | middle | 16 |
| other | animal | 16 |
| other | patients | 16 |
| small | animal | 15 |
| viral | transmission | 15 |
| viral | diseases | 15 |
| epidemiological | outbreak | 15 |
| respiratory | virus | 15 |
| human | cells | 15 |
| - | mers | 14 |
| higher | mers | 14 |
| first | patient | 13 |
| highest | risk | 13 |
| human | cell | 13 |
| infectious | mers | 13 |
| novel | viruses | 13 |
| positive | cases | 13 |
| - | middle | 12 |
| clinical | disease | 12 |
| epidemiological | studies | 12 |
| infected | mice | 12 |
| many | cases | 12 |
| potential | mers | 12 |
| several | days | 12 |
| others | viruses | 11 |
| different | mers | 11 |
| largest | outbreak | 11 |
| - | country | 10 |
| - | virus | 10 |
| large | case | 10 |
| many | studies | 10 |
| - | cells | 9 |
| - | outbreaks | 9 |
| - | patients | 9 |
| human | case | 9 |
| specific | mers | 9 |
| more | cases | 8 |
| specific | antibody | 8 |
| severe | infection | 8 |
| several | countries | 8 |
| novel | virus | 8 |
| - | contact | 8 |
| immune | cells | 8 |
| - | transmission | 8 |
| - | outbreak | 8 |
| - | day | 8 |
| earlier | studies | 8 |
| infected | cells | 7 |
| such | studies | 7 |
| severe | outbreaks | 7 |
| other | cases | 7 |
| other | coronavirus | 7 |
| human | transmissions | 7 |
| human | sars | 7 |
| epidemiological | study | 7 |
| different | cell | 7 |
| - | sars | 7 |
| more | transmissions | 6 |
| such | patients | 6 |
| small | study | 6 |
| several | mers | 6 |
| several | animal | 6 |
| potential | transmission | 6 |
| positive | mers | 6 |
| novel | cov | 6 |
| new | middle | 6 |
| human | contact | 6 |
| low | risk | 6 |
| infected | animal | 6 |
| human | diseases | 6 |
| - | east | 6 |
| human | antibody | 6 |
| acute | middle | 6 |
| - | infections | 6 |
| large | mers | 6 |
| largest | mers | 5 |
| viral | outbreaks | 5 |
| viral | disease | 5 |
| specific | camel | 5 |
| new | mers | 5 |
| more | days | 5 |
| lower | risk | 5 |
| many | patients | 5 |
| immune | cell | 5 |
| humans | middle | 5 |
| humans | mers | 5 |
| first | day | 5 |
| different | animal | 5 |
| - | mouse | 5 |
| - | disease | 5 |
| potential | outbreaks | 4 |
| novel | mers | 4 |
| positive | camels | 4 |
| positive | patients | 4 |
| potential | contacts | 4 |
| small | case | 4 |
| several | patients | 4 |
| severe | infections | 4 |
| new | case | 4 |
| viral | protein | 4 |
| new | cases | 4 |
| human | virus | 4 |
| more | infections | 4 |
| high | antibody | 4 |
| infected | camel | 4 |
| - | camel | 4 |
| - | contacts | 4 |
| first | study | 4 |
| different | viruses | 4 |
| higher | case | 4 |
| human | outbreaks | 4 |
| human | studies | 4 |
| potential | outbreak | 3 |
| other | risk | 3 |
| other | study | 3 |
| other | camels | 3 |
| other | virus | 3 |
| positive | case | 3 |
| positive | cells | 3 |
| specific | countries | 3 |
| several | cases | 3 |
| several | mouse | 3 |
| several | proteins | 3 |
| small | animals | 3 |
| such | antibodies | 3 |
| such | cases | 3 |
| such | outbreaks | 3 |
| novel | sars | 3 |
| other | camel | 3 |
| new | animal | 3 |
| new | outbreaks | 3 |
| first | outbreak | 3 |
| new | infections | 3 |
| clinical | cases | 3 |
| early | case | 3 |
| early | days | 3 |
| epidemiological | risk | 3 |
| first | middle | 3 |
| early | risk | 3 |
| high | mers | 3 |
| human | cov | 3 |
| infected | cell | 3 |
| infectious | cases | 3 |
| many | outbreaks | 3 |
| more | studies | 3 |
| new | infection | 3 |
| other | contacts | 2 |
| positive | camel | 2 |
| other | patient | 2 |
| other | mouse | 2 |
| other | infections | 2 |
| other | disease | 2 |
| other | day | 2 |
| other | cov | 2 |
| new | disease | 2 |
| other | contact | 2 |
| other | cell | 2 |
| new | viruses | 2 |
| new | syndrome | 2 |
| new | sars | 2 |
| new | diseases | 2 |
| potential | middle | 2 |
| more | proteins | 2 |
| potential | animal | 2 |
| severe | coronavirus | 2 |
| potential | risks | 2 |
| potential | studies | 2 |
| viral | outbreak | 2 |
| such | transmission | 2 |
| such | mers | 2 |
| such | animals | 2 |
| specific | risk | 2 |
| smaller | outbreaks | 2 |
| small | outbreaks | 2 |
| severe | syndrome | 2 |
| severe | sars | 2 |
| many | viruses | 2 |
| several | viruses | 2 |
| several | sars | 2 |
| several | risk | 2 |
| several | outbreaks | 2 |
| respiratory | cases | 2 |
| more | mers | 2 |
| different | animals | 2 |
| many | mers | 2 |
| common | disease | 2 |
| earlier | study | 2 |
| earlier | cases | 2 |
| different | study | 2 |
| different | studies | 2 |
| different | mouse | 2 |
| different | infection | 2 |
| different | covs | 2 |
| clinical | syndrome | 2 |
| early | outbreak | 2 |
| clinical | study | 2 |
| clinical | case | 2 |
| available | mers | 2 |
| acute | infection | 2 |
| acute | disease | 2 |
| - | study | 2 |
| larger | study | 2 |
| early | mers | 2 |
| - | cases | 2 |
| early | transmission | 2 |
| human | covs | 2 |
| first | animal | 2 |
| large | animal | 2 |
| infectious | outbreak | 2 |
| infected | contacts | 2 |
| infected | cases | 2 |
| immune | antibodies | 2 |
| human | patients | 2 |
| larger | outbreak | 2 |
| human | contacts | 2 |
| higher | disease | 2 |
| high | virus | 2 |
| first | mouse | 2 |
| first | days | 2 |
| higher | virus | 2 |
| first | countries | 2 |
| other | case | 1 |
| more | transmission | 1 |
| new | cov | 1 |
| new | mouse | 1 |
| novel | covs | 1 |
| novel | disease | 1 |
| novel | mouse | 1 |
| other | proteins | 1 |
| other | diseases | 1 |
| other | outbreak | 1 |
| positive | animals | 1 |
| positive | contacts | 1 |
| potential | cases | 1 |
| potential | cov | 1 |
| more | patients | 1 |
| several | contacts | 1 |
| respiratory | cells | 1 |
| many | animals | 1 |
| more | animals | 1 |
| many | risk | 1 |
| several | middle | 1 |
| low | mers | 1 |
| low | patient | 1 |
| low | transmission | 1 |
| low | virus | 1 |
| lower | case | 1 |
| lower | infection | 1 |
| lower | mers | 1 |
| lower | virus | 1 |
| many | animal | 1 |
| many | case | 1 |
| many | cell | 1 |
| many | days | 1 |
| many | diseases | 1 |
| many | mouse | 1 |
| several | infections | 1 |
| specific | disease | 1 |
| several | virus | 1 |
| specific | infection | 1 |
| specific | risks | 1 |
| specific | sars | 1 |
| specific | studies | 1 |
| specific | study | 1 |
| specific | transmission | 1 |
| specific | virus | 1 |
| such | contact | 1 |
| such | countries | 1 |
| such | diseases | 1 |
| such | infection | 1 |
| such | outbreak | 1 |
| such | risks | 1 |
| such | virus | 1 |
| such | viruses | 1 |
| viral | antibodies | 1 |
| specific | protein | 1 |
| specific | diseases | 1 |
| severe | case | 1 |
| low | cases | 1 |
| severe | diseases | 1 |
| severe | outbreak | 1 |
| severe | patient | 1 |
| severe | patients | 1 |
| small | antibodies | 1 |
| small | countries | 1 |
| small | studies | 1 |
| smaller | countries | 1 |
| smaller | studies | 1 |
| smallest | animal | 1 |
| specific | % | 1 |
| specific | animals | 1 |
| specific | case | 1 |
| specific | contact | 1 |
| specific | contacts | 1 |
| low | infection | 1 |
| immune | camel | 1 |
| low | case | 1 |
| common | infection | 1 |
| different | cells | 1 |
| different | country | 1 |
| different | cov | 1 |
| different | infections | 1 |
| different | proteins | 1 |
| different | risks | 1 |
| earlier | mouse | 1 |
| earlier | outbreaks | 1 |
| earliest | cases | 1 |
| early | animal | 1 |
| early | cases | 1 |
| early | studies | 1 |
| early | virus | 1 |
| epidemiological | case | 1 |
| first | antibodies | 1 |
| common | transmission | 1 |
| common | diseases | 1 |
| first | cov | 1 |
| common | case | 1 |
| - | al | 1 |
| - | arabia | 1 |
| - | case | 1 |
| - | saudi | 1 |
| acute | diseases | 1 |
| acute | mers | 1 |
| acute | patients | 1 |
| acute | virus | 1 |
| available | cases | 1 |
| available | studies | 1 |
| clinical | diseases | 1 |
| clinical | mers | 1 |
| clinical | outbreaks | 1 |
| clinical | risk | 1 |
| clinical | syndromes | 1 |
| first | antibody | 1 |
| first | infection | 1 |
| low | antibody | 1 |
| immune | animal | 1 |
| infected | case | 1 |
| infected | contact | 1 |
| infected | mouse | 1 |
| infected | sars | 1 |
| infectious | outbreaks | 1 |
| infectious | viruses | 1 |
| large | cells | 1 |
| large | studies | 1 |
| large | transmission | 1 |
| larger | animal | 1 |
| larger | countries | 1 |
| largest | camel | 1 |
| largest | middle | 1 |
| largest | outbreaks | 1 |
| largest | study | 1 |
| immune | camels | 1 |
| humans | transmission | 1 |
| first | outbreaks | 1 |
| humans | patient | 1 |
| first | studied | 1 |
| high | patient | 1 |
| high | protein | 1 |
| high | transmission | 1 |
| higher | infection | 1 |
| higher | sars | 1 |
| higher | transmission | 1 |
| highest | antibody | 1 |
| highest | country | 1 |
| highest | infection | 1 |
| highest | mers | 1 |
| highest | transmission | 1 |
| human | patient | 1 |
| human | viruses | 1 |
| humans | infection | 1 |
| viral | transmissions | 1 |